FDA Inspection 1119599 — Raed Al-Rajabi, MD

Raed Al-Rajabi, MD — FEI 3015978004

The FDA completed an inspection of Raed Al-Rajabi, MD on February 7, 2020 in Westwood, KS. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 7, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Westwood, KS (United States)

Additional Details

Clinical Investigator (CI)